Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/66997
Type
ArticleCopyright
Restricted access
Collections
- INI - Artigos de Periódicos [3505]
Metadata
Show full item record
HEART FAILURE ASSOCIATED WITH CHRONIC CHAGAS CARDIOMYOPATHY INCREASES THE RISK OF IMPAIRED LUNG FUNCTION AND REDUCED SUBMAXIMAL FUNCTIONAL CAPACITY
Spirometry
Submaximal functional capacity
Six-minute step test
Lung function
Author
Silva, Patrício Braz da
Diniz, Clara Pinto
Mediano, Mauro Felippe Felix
Mendes, Fernanda de Souza Nogueira Sardinha
Hasslocher-Moreno, Alejandro Marcel
Reis, Luis Felipe da Fonseca
Reis, Michel Silva
Saraiva, Roberto Magalhães
Holanda, Marcelo Teixeira de
Rocha, Flavia Mazzoli da
Sousa, Andréa Silvestre de
Diniz, Clara Pinto
Mediano, Mauro Felippe Felix
Mendes, Fernanda de Souza Nogueira Sardinha
Hasslocher-Moreno, Alejandro Marcel
Reis, Luis Felipe da Fonseca
Reis, Michel Silva
Saraiva, Roberto Magalhães
Holanda, Marcelo Teixeira de
Rocha, Flavia Mazzoli da
Sousa, Andréa Silvestre de
Affilliation
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Instituto Nacional de Cardiologia. Coordenação de Ensino e Pesquisa. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Centro Universitário Augusto Motta. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Instituto Nacional de Cardiologia. Coordenação de Ensino e Pesquisa. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Centro Universitário Augusto Motta. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro. Rio de Janeiro, RJ, Brasil.
Abstract
Background: With the evolution of chronic Chagas cardiomyopathy (CC) and the progression towards heart failure (HF), patients may show a decline in inspiratory muscle strength, lung function, and functional capacity. Objective: We compared respiratory function and submaximal functional capacity in patients with CC with versus without HF. Methods: This observational, cross-sectional study was carried out with CC patients divided into CCG, a group without HF (n = 28), and HFG, a group with HF (n = 27). Spirometry (percent predicted forced vital capacity (ppFVC), forced expiratory volume in one second of FVC (ppFEV₁), forced expiratory flow between 25 % and 75 % of FVC (ppFEF₂₅-₇₅ ﹪), and maximum voluntary ventilation (ppMVV)) and submaximal functional capacity (six-minute step test: 6MST) were evaluated. Mann-Whitney (comparison of pulmonary function and functional capacity between groups) and linear regression (association between the presence of HF and other variables) were performed. Results: We included 55 participants, with median age of 67 years (56.25–71.75) and 54.55 % males. Dyslipidemia was the most recurrent comorbidity (49.09 %). HFG presented lower ppFVC (P = 0.000), ppFEV₁ (P = 0.011), ppFEF₂₅-₇₅ ﹪ (P = 0.017), and ppMVV (P = 0.003) than the CCG. The ppFVC (B = -18.95; P = 0.000), ppFEV₁ (B = -16.29; P = 0.021), ppFEF₂₅-₇₅ ﹪ (B = -19.57; P = 0.014), ppMVV (B = -16.59; P = 0.003), and 6MST (B = -17.13; P = 0.034) were negatively associated with the presence of HF. Conclusion: Our data suggest that impaired lung function, compatible with a restrictive pulmonary pattern, is present among adults with CC and HF.
Keywords
Chagas cardiomyopathySpirometry
Submaximal functional capacity
Six-minute step test
Lung function
Share